Prana Biotechnology Limited (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 45   

Articles published

PRAN 2.14 -0.09 (-4.04%)
price chart
Know before you invest: Prana Biotechnology Limited (ADR) (NASDAQ:PRAN ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) soared 18.69% on Friday as it has been granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease by the US Food and Drug Administration (FDA).
Stocks In News: Prana Biotechnology Limited (ADR)(NASDAQ:PRAN), GoPro ...  US Trade Media
Traders Recap - Pixelworks, Inc. (NASDAQ:PXLW), Prana Biotechnology Limited ...  Techsonian (press release)
Related articles »  
Stocks Roundup- Prana Biotechnology Limited (ADR) (NASDAQ:PRAN ...
Birmingham, West Midlands - (TechSonian) - 12th September 2014 - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) reported that its Phase 2 REACH2HD clinical trial investigating PBT2 as a cure for Huntington disease met its primary safety ...
Related articles »  
Worth Watching Stocks: BP plc (BP), Prana Biotechnology Limited (PRAN), B/E ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) is flying high today after the development stage company reported that FDA has given Orphan Drug designation to PBT2.
Morning Buzz: Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Infoblox ...  Market News Call
Morning Buzz - FuelCell Energy Inc (NASDAQ:FCEL), Prana Biotechnology ...  Techsonian (press release)
Related articles »  
Investors Alert : Vale S.A. (NYSE:VALE), Prana Biotechnology Limited (NASDAQ ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) is flying high after the development stage company reported that FDA has given Orphan Drug designation to PBT2.
Related articles »  
Traders Recap - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN), Curis ...
Manhattan, NY- Aug 21, 2014 - (Techsonian) - Prana Biotechnology Limited (ADR) (NASDAQ:PRAN)researches and develops therapeutic drugs for the treatment of neurological disorders in Australia.
Stock Buzz-Ion Geophysical Corp (IO), Prana Biotechnology Limited (ADR ...
Las Vegas, NV - August 29, 2014 - (Tech Sonian) - Ion Geophysical Corp (NYSE:IO) reported that Brian Hanson, ION's President and Chief Executive Officer, and Greg Heinlein, Senior Vice President and Chief Financial Officer, will be attending the ...
Related articles »  
News Buzz: Genworth Financial (NYSE:GNW), Prana Biotechnology Limited ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) is being back of orphan drug designation for its drug PBT2. The drug is being developed to be used for the treatment of Huntington's disease.
Related articles »  
4 Big Selloffs: Orexigen Therapeutics, Inc. (NASDAQ:OREX), Pacific Ethanol Inc ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) gave back some of gains made after being granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease by the US Food and Drug Administration (FDA).
Related articles »  
Investors Alert: Baidu Inc (ADR) (NASDAQ:BIDU), Himax Technologies, Inc ...
On 15 AUG Prana Biotechnology Limited (NASDAQ:PRAN) said that shares of Prana Biotechnology Limited (NASDAQ:PRAN) were the target of a significant growth in short interest in July.
Related articles »  
Best Stocks on Wall Street: Net Element International Inc (NETE), Mandalay ...
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) rose again as it has been granted Orphan Drug designation to PBT2 for the treatment of Huntington Disease by the US Food and Drug Administration (FDA).